Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Dyscrasia Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02143414
What this trial is testing

Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaB Acute Lymphoblastic LeukemiaB Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1+2 more
National Cancer Institute (NCI) 53
Large-scale testing (Phase 3)Not Yet RecruitingNCT07072585
What this trial is testing

Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)

Who this might be right for
Stage II T Lymphoblastic Leukemia/LymphomaStage III T Lymphoblastic Leukemia/LymphomaStage IV T Lymphoblastic Leukemia/Lymphoma+2 more
Children's Oncology Group 1,708
Not applicableStudy completedNCT01352585
What this trial is testing

Exploratory Multi-centre Trial In Patients With ET Treated With XAGRID®

Who this might be right for
Essential Thrombocythemia (ET)
Shire 47
Not applicableStudy completedNCT00499785
What this trial is testing

Physical and Mental Assessment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Cognitive/Functional EffectsDepressionLeukemia
Wake Forest University Health Sciences 11
Not applicableUnknownNCT02750085
What this trial is testing

Evaluation of a Simple Pharmacokinetic Tool (myPKFiT™) to Guide Personalized Factor VIII Dosing in Patients With Hemophilia

Who this might be right for
Hemophilia A
Victor Blanchette 39
Early research (Phase 1)Study completedNCT03602235
What this trial is testing

High Dose Ascorbic Acid for Plasma Cell Disorders

Who this might be right for
Multiple Myeloma
Christopher Strouse 6
Not applicableLooking for participantsNCT06891599
What this trial is testing

ROTEM in Sepsis Trauma Outcome in Intensive Care

Who this might be right for
Sepsis - to Reduce Mortality in the Intensive Care UnitTrauma Coagulopathy
Region Stockholm 600
Very early researchWithdrawnNCT03591614
What this trial is testing

Dendritic Cell DKK1 Vaccine for Monoclonal Gammopathy and Stable or Smoldering Myeloma

Who this might be right for
Monoclonal GammopathySmoldering MyelomaMyeloma
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06465433
What this trial is testing

Extension Study to Provide Continued Treatment for Patients With Hematologic Malignancies Previously Enrolled in Studies With Tafasitamab

Who this might be right for
Hematologic Malignancies
Incyte Corporation 25
Testing effectiveness (Phase 2)Study completedNCT00003335
What this trial is testing

Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Case Comprehensive Cancer Center 44
Early research (Phase 1)Study completedNCT02611063
What this trial is testing

Evaluation of Fostamatinib in Patients With cGVHD After Allogeneic Stem Cell Transplant

Who this might be right for
Hematological Malignancies
Stefanie Sarantopoulos, MD, PhD. 22
Early research (Phase 1)Study completedNCT00006221
What this trial is testing

BMS-247550 in Treating Patients With Advanced Cancers

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)WithdrawnNCT00003984
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndromes
European Organisation for Research and Treatment of Cancer - EORTC
Early research (Phase 1)Study completedNCT05225584
What this trial is testing

Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors

Who this might be right for
Non Hodgkin Lymphoma (NHL)Peripheral T-cell Lymphoma (PTCL)Cutaneous T-Cell Lymphoma (CTCL)+3 more
Kymera Therapeutics, Inc. 56
Not applicableEnded earlyNCT01517347
What this trial is testing

Efficiency Study of Low Dose of IL-2 to Prevent Relapse in Standard Risk Leukemia After Transplantation

Who this might be right for
Leukemia
Peking University People's Hospital 90
Testing effectiveness (Phase 2)Looking for participantsNCT04742634
What this trial is testing

Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant

Who this might be right for
Myelodysplastic Syndromes
Washington University School of Medicine 209
Testing effectiveness (Phase 2)Study completedNCT00806598
What this trial is testing

Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromeAplastic Anemia
M.D. Anderson Cancer Center 53
Testing effectiveness (Phase 2)Ended earlyNCT00909363
What this trial is testing

Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients

Who this might be right for
Wiskott-Aldrich SyndromeThrombocytopeniaBleeding
Weill Medical College of Cornell University 24
Testing effectiveness (Phase 2)WithdrawnNCT00845104
What this trial is testing

Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To Treatment

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic Leukemia
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Testing effectiveness (Phase 2)Temporarily pausedNCT02910752
What this trial is testing

CLAM Chemotherapy With PBSC Support for Relapsed Patients After Allogeneic Stem Cell Transplantation

Who this might be right for
Leukemia
Shanghai Jiao Tong University School of Medicine 20
Next Page